Medco Gets Personal: LabCorp Agreement Pairs Cancer Med With AmpliChip
This article was originally published in The Gray Sheet
Executive Summary
The pharmacy benefit manager Medco is working with the Laboratory Corporation of America to develop data on a personalized medicine approach to the use of the breast cancer drug tamoxifen